Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A - Asset Resilience Ratio
Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A (301290) has an Asset Resilience Ratio of 46.10% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2020–2024)
This chart shows how Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A's Asset Resilience Ratio has changed over time. See financial agility of Jiangsu Canopus Wisdom Medical Technolog to measure the company's free cash flow as a share of total liabilities.
Liquid Assets Composition Over Time
This chart breaks down Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 301290 stock market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥1.14 Billion | 46.1% |
| Total Liquid Assets | CN¥1.14 Billion | 46.10% |
Asset Resilience Insights
- Very High Liquidity: Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A maintains exceptional liquid asset reserves at 46.10% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A Industry Peers by Asset Resilience Ratio
Compare Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Novocure Ltd
NASDAQ:NVCR |
Medical Devices | 43.72% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317 |
Medical Devices | 10.88% |
|
Bactiguard Holding AB (publ)
ST:BACTI-B |
Medical Devices | 8.12% |
|
Oncosil Medical Ltd
AU:OSL |
Medical Devices | 0.00% |
|
Anteris Technologies Global Corp
AU:AVR |
Medical Devices | 33.27% |
Annual Asset Resilience Ratio for Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A (2020–2024)
The table below shows the annual Asset Resilience Ratio data for Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 36.50% | CN¥906.06 Million ≈ $132.59 Million |
CN¥2.48 Billion ≈ $363.26 Million |
+8.33pp |
| 2023-12-31 | 28.17% | CN¥674.29 Million ≈ $98.67 Million |
CN¥2.39 Billion ≈ $350.26 Million |
+23.15pp |
| 2022-12-31 | 5.02% | CN¥119.75 Million ≈ $17.52 Million |
CN¥2.38 Billion ≈ $348.82 Million |
+0.57pp |
| 2021-12-31 | 4.45% | CN¥55.40 Million ≈ $8.11 Million |
CN¥1.24 Billion ≈ $182.09 Million |
+0.20pp |
| 2020-12-31 | 4.25% | CN¥48.60 Million ≈ $7.11 Million |
CN¥1.14 Billion ≈ $167.28 Million |
-- |
About Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A
Jiangsu Canopus Wisdom Medical Technology Co.,Ltd. engages in the research, development, manufacture, and sale of surgical medical devices and spare parts in China. It offers orthopedic traction frames, surgical lamps, hospital system integration solutions, electric gynecological examination tables, obstetrics and gynecology examination tables, electric operating tables, multi-functional intellig… Read more